Clinical isolate of Citrobacter freundii highly resistant to new quinolones.
About 30% of 150 recent clinical isolates of Citrobacter freundii were resistant to greater than or equal to 3.13 micrograms of norfloxacin and ofloxacin per ml. Study of one quinolone-resistant strain for which the norfloxacin MIC was 100 micrograms/ml suggested that resistance was associated with...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1988
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172307/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2843087/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.6.922 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|